Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07311889

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

Assessment of Patient Satisfaction and Healing Outcomes With the ELIXIR MD™ Device in the Perioperative Period of Plastic Surgery

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Elixir MD Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this observational registry study is to characterize postoperative recovery outcomes in adult patients receiving standard-of-care perioperative light therapy using an FDA-cleared photobiomodulation device as part of routine clinical practice. The study aims to describe changes in patient-reported and clinician-assessed recovery measures following elective surgical procedures. The main questions this registry aims to answer are: 1. How do patient-reported recovery outcomes, including pain, satisfaction, and perceived improvement, change over the postoperative period? 2. How do clinician-assessed indicators of recovery, such as swelling and bruising, change over time following surgery? This study does not include a randomized comparison group. Outcomes will be described longitudinally within participants based on data collected during routine care. Participants will: 1. Receive perioperative light therapy as part of standard clinical care, per their treating clinician 2. Complete patient-reported outcome questionnaires at defined postoperative time points 3. Undergo standardized clinical photography and routine clinical assessments as part of usual follow-up

Conditions

Interventions

TypeNameDescription
OTHERPerioperative photobiomodulation light therapyParticipants may receive perioperative light therapy as part of routine clinical care at the discretion of their treating clinician. The study does not assign, modify, or mandate the use of light therapy. Data are collected observationally to describe recovery outcomes associated with standard clinical practice.

Timeline

Start date
2026-01-19
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2025-12-31
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07311889. Inclusion in this directory is not an endorsement.